Test Directory
Heparin Level (UFH)
Justification
Heparin monitoring may be warranted in kidney disease, pregnancy, cancer, geriatric, obese patient populations and when bleeding is observed. Note: monitoring heparin with the aPTT in patients with lupus anticoagulants may be unreliable.
STAT: < 1 week
Chromogenic
Draw Tube: Blue Top
Sample Type: Citrated Plasma
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | Citrated Plasma | 1mL | 0.5mL | Frozen (-20C): 2 weeks Frozen (-80C): 6 months |
ALTERNATIVE | - | - | - | - |
REJECTION CRITERIA | Thawed in transit, refrozen or clotted sample |
SPECIAL INSTRUCTIONS | - |
General Information
METHODOLOGY | Chromogenic |
STAT TAT | < 1 week |
STAT TAT Performance | > 90% of results released in 1 week |
ROUTINE TAT | < 1 week |
ALTERNATIVE NAMES | UFH level, aXa |
DESCRIPTION | - |
LIMITATIONS | - |
NORMAL RANGE | - |
ASSOCIATED TESTING | - |
REFERENCES | - |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | No |
Test Codes
ORDER CODE | P3349 |
CPT CODE | 85520 |
LOINC CODE | 3274-8 |